ID: ALA2023986

Max Phase: Preclinical

Molecular Formula: C37H33N3O7S

Molecular Weight: 663.75

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(S(=O)(=O)N(C)CC(=O)N(Cc2ccc(-c3ccc(-c4ccc(C(N)=O)cc4)cc3)cc2)c2ccc(C(=O)O)c(O)c2)cc1

Standard InChI:  InChI=1S/C37H33N3O7S/c1-24-3-18-32(19-4-24)48(46,47)39(2)23-35(42)40(31-17-20-33(37(44)45)34(41)21-31)22-25-5-7-26(8-6-25)27-9-11-28(12-10-27)29-13-15-30(16-14-29)36(38)43/h3-21,41H,22-23H2,1-2H3,(H2,38,43)(H,44,45)

Standard InChI Key:  KOVXOSJQVVRPFQ-UHFFFAOYSA-N

Associated Targets(Human)

Signal transducer and activator of transcription 5B 90 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Signal transducer and activator of transcription 3 3313 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Signal transducer and activator of transcription 1-alpha/beta 808 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Signal transducer and activator of transcription 3 376 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 663.75Molecular Weight (Monoisotopic): 663.2039AlogP: 5.69#Rotatable Bonds: 11
Polar Surface Area: 158.31Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.85CX Basic pKa: CX LogP: 6.19CX LogD: 2.70
Aromatic Rings: 5Heavy Atoms: 48QED Weighted: 0.16Np Likeness Score: -1.12

References

1. Page BD, Khoury H, Laister RC, Fletcher S, Vellozo M, Manzoli A, Yue P, Turkson J, Minden MD, Gunning PT..  (2012)  Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.,  55  (3): [PMID:22148584] [10.1021/jm200720n]
2. Debnath B, Xu S, Neamati N..  (2012)  Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein.,  55  (15): [PMID:22650325] [10.1021/jm300207s]

Source